ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 67 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $57,000 | -61.7% | 19,873 | -43.4% | 0.01% | -65.0% |
| Q3 2021 | $149,000 | +9.6% | 35,086 | +36.4% | 0.02% | -56.5% |
| Q2 2021 | $136,000 | +40.2% | 25,718 | +23.8% | 0.05% | +48.4% |
| Q1 2021 | $97,000 | +40.6% | 20,778 | 0.0% | 0.03% | +55.0% |
| Q4 2020 | $69,000 | -59.2% | 20,778 | -59.3% | 0.02% | -63.0% |
| Q3 2020 | $169,000 | +21.6% | 51,028 | +24.0% | 0.05% | +14.9% |
| Q2 2020 | $139,000 | +13.0% | 41,148 | +28.6% | 0.05% | -9.6% |
| Q1 2020 | $123,000 | – | 32,006 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 2,679,457 | $20,257,000 | 0.73% |
| Portolan Capital Management | 777,293 | $5,876,000 | 0.66% |
| CAMPBELL CAPITAL MANAGEMENT INC | 110,451 | $835,000 | 0.62% |
| ZEKE CAPITAL ADVISORS, LLC | 402,212 | $3,041,000 | 0.27% |
| Leap Investments LP | 46,084 | $348,000 | 0.17% |
| Bernardo Wealth Planning LLC | 26,419 | $199,000 | 0.14% |
| Claraphi Advisory Network, LLC | 14,744 | $111,000 | 0.07% |
| Sterling Investment Advisors, Ltd. | 11,000 | $83,000 | 0.04% |
| A.R.T. Advisors, LLC | 81,372 | $615,000 | 0.03% |
| Mirae Asset Global Investments Co., Ltd. | 544,408 | $4,116,000 | 0.03% |